ELVN-002

· Enliven Therapeutics

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ELVN-002, covering 2025-07-15 to 2025-11-19. Get the full timeline:

Most recent: Clinical Trial Update: ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer [Phase 1]